EGFR and cancer: However, when expressed in certain cancer cell lines (e.g., SKBr3 breast cancer cells), the reporter exhibits an enhanced plasma membrane localization [28], even under serum-starved conditions, that is likely due to constitutive activation of signaling pathways (e.g., EGFR activation or Her2 overexpression) that lead to activation of PI3K in the absence of exogenous stimuli.